Related Experiment Video
Updated: Feb 25, 2026
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Inflammatory bowel disease in adolescents
Insights
Pediatric inflammatory bowel disease (IBD) is aggressive, impacting growth and development. Current treatments focusing only on symptoms are insufficient; aiming for mucosal healing is crucial for better outcomes in adolescents with IBD.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease (IBD) Research
- Adolescent Health
Background:
- Approximately 20% of inflammatory bowel disease (IBD) cases are diagnosed in pediatric populations.
- Pediatric-onset IBD often presents with a more complicated and aggressive disease course compared to adult-onset IBD.
- General practitioners (GPs) play a critical role in the early diagnosis and ongoing management of pediatric IBD.
Purpose of the Study:
- To highlight the distinct characteristics of pediatric-onset IBD versus adult-onset IBD.
- To discuss updated treatment targets for pediatric IBD.
- To address practical management considerations for adolescents with IBD.
Main Methods:
- Review of current literature on pediatric IBD.
- Analysis of differences in disease presentation and progression between pediatric and adult IBD.
- Evaluation of treatment strategies and end-points in adolescent IBD management.
Main Results:
- Pediatric IBD is characterized by aggressive disease, growth failure, delayed puberty, and psychosocial challenges.
- Symptom control alone is inadequate for preventing long-term intestinal damage in pediatric IBD.
- Newer treatment goals emphasize achieving high rates of intestinal mucosal healing.
Conclusions:
- IBD in children and adolescents is more aggressive and presents unique challenges including growth and psychosocial development.
- Traditional symptom-focused treatment targets for IBD are insufficient to prevent ongoing bowel damage.
- Achieving intestinal mucosal healing represents a more effective treatment end-point for managing adolescent IBD.
Background:
Nearly 20% of all inflammatory bowel disease (IBD) is diagnosed in children and adolescents, where it follows a more compli-cated and aggressive course than adult-onset IBD. General practitioners (GPs) have a pivotal role in early diagnosis, and monitoring and supporting children and families with IBD.
Objective:
This article will focus on recognising key differences between paediatric-onset IBD and adult-onset IBD, proposed treatment targets, and practical issues in the management of adolescents with IBD.
Discussion:
IBD in children is more aggressive in nature, with additional issues of growth failure, delayed puberty and the consequences of a chronic disease commencing at a vulnerable period of psychosocial development. Traditional treatment targets focus on symptom control, but this is insufficient as long-term, end-organ (bowel) damage results from insufficiently controlled inflammation. In this article, we provide a brief overview of IBD in adolescents and cover key management issues, particularly focusing on newer treatment end-points by aiming for high rates of intestinal mucosal healing and evidence to support this approach.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: